MedTrace Logo

Autologous Transplantation of Mesenchymal Stem Cells (MSCs) and Scaffold in Full-thickness Articular Cartilage

NCT00850187 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 6

Last updated 2012-01-05

No results posted yet for this study

Summary

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Bone Marrow Mesenchymal stem cells (MSCs) mixed with collagen I scaffold in patient with Knee cartilage defects and osteoarthritis

Conditions

Interventions

BIOLOGICAL

Bone marrow derived mesenchymal stem cells

Bone Marrow Aspiration A total volume of 300 ml bone marrow will be aspirated from the iliac crest and are cultured for mesenchymal stem cells

Sponsors & Collaborators

  • Tehran University of Medical Sciences

    collaborator OTHER

  • Royan Institute

    lead OTHER_GOV

Principal Investigators

  • Hamid gourabi, PhD · Chief

  • Mohamadreza Baghaban Eslaminejad, PhD · Scientific Board

  • Leila Taghiyar, Msc · Researcher

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-31
Primary Completion
2010-07-31
Completion
2010-12-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00850187 on ClinicalTrials.gov